Bourne Lent Asset Management Q3 vs. Q4 2022 Holding Changes Analysis

Bourne Lent Asset Management Inc Q3 2022 vs. Q4 2022 13F Holdings Comparison

Bourne Lent Asset Management is a leading asset management firm located in Philadelphia. The firm has recently filed its 13F with the SEC, which discloses the holdings of the firm in Q3 2022 and Q4 2022. The 13F Holdings Comparison provides a comparison of the holdings in both quarters, which helps in understanding the changes in the firm’s portfolio.

The comparison reveals that the firm has made several changes to its holdings in Q4 2022. Some of the significant changes are discussed below:

Apple Inc (AAPL)

The firm has decreased its holdings in Apple Inc by 8.3% in Q4 2022. The firm owned 175,906 shares of the tech giant in Q3 2022, which decreased to 171,627 shares in Q4 2022. The value of the holdings decreased from $24,310,000 to $22,299,000. The decrease in the holdings may be attributed to the regulatory scrutiny that Apple has been facing in recent times.

Bristol-Myers Squibb Co (BMY)

Bourne Lent Asset Management has decreased its holdings in Bristol-Myers Squibb Co by a significant 27% in Q4 2022. The firm owned 293,528 shares of the pharmaceutical company in Q3 2022, which decreased to 211,653 shares in Q4 2022. The value of the holdings decreased from $20,867,000 to $15,228,000. The decrease in the holdings may be attributed to concerns over the company’s future growth prospects.

Amazon.com, Inc (AMZN)

The firm has decreased its holdings in Amazon.com Inc by 26.1% in Q4 2022. The firm owned 53,500 shares of the e-commerce giant in Q3 2022, which decreased to 53,190 shares in Q4 2022. The value of the holdings decreased from $6,045,000 to $4,467,000. The decrease in the holdings may be attributed to concerns over the company’s regulatory and antitrust issues.

PacBio (PACB)

Bourne Lent Asset Management has increased its holdings in Pacific Biosciences of California Inc by a significant 42.7% in Q4 2022. The firm owned 584,150 shares of the biotechnology company in Q3 2022, which increased to 591,450 shares in Q4 2022. The value of the holdings increased from $3,391,000 to $4,838,000. The increase in the holdings may be attributed to the growth prospects of the company in the biotechnology sector.

Tesla Inc (TSLA)

The firm has decreased its holdings in Tesla Inc by a significant 70.1% in Q4 2022. The firm owned 12,600 shares of the electric vehicle maker in Q3 2022, which decreased to 8,100 shares in Q4 2022. The value of the holdings decreased from $3,342,000 to $997,000. The decrease in the holdings may be attributed to concerns over the company’s valuation and growth prospects.

Other Changes

The firm has also made other significant changes in its holdings in Q4 2022. For example, the firm has increased its holdings in Intuitive Surgical Inc by 23.7%, while it has decreased its holdings in Illumina Inc by 31.5%. The firm has also sold its entire holdings in Symbotic Inc and RA Medical Systems Inc in Q4 2022.

Conclusion

Bourne Lent Asset Management has made significant changes to its holdings in Q4 2022. The firm has decreased its holdings in some of the leading tech and pharma companies, while it has increased its holdings in some of the biotechnology companies. The changes in the holdings indicate that the firm is closely monitoring the regulatory and growth prospects of the companies in its portfolio. The 13F Holdings Comparison provides useful insights into the firm’s investment strategy and helps in understanding the changes in the firm’s holdings.